Atossa pulls IPO

Atossa Genetics Inc. (Seattle, Wash.) withdrew its IPO and said it is not "practicable" to pursue the offering at this time. In October, the company refiled to sell up to 3 million units at $5-$7 in an offering underwritten by Dawson James Securities on the NYSE Amex. At Sept. 30, 2010, Atossa had $29,531 in cash and a nine-month operating loss of $739,557. In a February SEC filing, Atossa said it has $420,000 remaining on its line of credit from Founder and CEO Steven Quay. Last July, Atossa withdrew an IPO to raise up to $15 million on the OTC Bulletin Board. ...